Chapter 21. Alzheimer's Disease: Current Therapeutic Approaches
- 1 January 1993
- book chapter
- Published by Elsevier
Abstract
No abstract availableThis publication has 132 references indexed in Scilit:
- Thrombin accumulation in brains of patients with Alzheimer's diseaseNeuroscience Letters, 1992
- Protease inhibitors generate cytotoxic fragments from alzheimer amyloid protein precursor in cDNA-transfected glioma cellsBiochemical and Biophysical Research Communications, 1992
- Urea and 2-imidazolidone derivatives of the muscarinic agents oxotremorine and N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamideJournal of Medicinal Chemistry, 1992
- A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytesNature, 1992
- Syntheses, resolution, and structure-activity relationships of potent acetylcholinesterase inhibitors: 8-carbaphysostigmine analogsJournal of Medicinal Chemistry, 1992
- IL-6-mediated events in Alzheimer's disease pathologyImmunology Today, 1991
- Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's diseaseJournal of Molecular Biology, 1991
- Evidence for a preferential involvement of M1 muscarinic receptors in representational memoryNeuroscience Letters, 1990
- Tetrahydroaminoacridine–Lecithin Combination Treatment in Patients with Intermediate-Stage Alzheimer's DiseaseNew England Journal of Medicine, 1990
- Molecular pharmacology of muscarinic receptor heterogeneityLife Sciences, 1989